...
首页> 外文期刊>Journal of pharmaceutical sciences. >Conformational comparability of factor IX-Fc fusion protein, factor IX, and purified Fc fragment in the absence and presence of calcium.
【24h】

Conformational comparability of factor IX-Fc fusion protein, factor IX, and purified Fc fragment in the absence and presence of calcium.

机译:在不存在和存在钙的情况下,因子IX-Fc融合蛋白,因子IX和纯化的Fc片段的构象可比性。

获取原文
获取原文并翻译 | 示例
           

摘要

A long lasting recombinant factor IX -Fc fusion protein (rFIX-Fc) is being developed for the treatment of hemophilia B and is currently in late stage clinical investigation. By limiting injection frequency and maintaining efficacy, rFIX-Fc shows promise as a new therapeutic option for hemophilia B patients. However, before gaining regulatory approval, rFIX-Fc must undergo rigorous analytical and biological testing, in addition to clinical trials. Included in this testing is the need to understand this protein's higher-order structure and dynamics. In this study, we investigated and compared the biophysical properties of rFIX-Fc, rFIX, and Fc using hydrogen/deuterium exchange mass spectrometry and differential scanning calorimetry. Within the limits of these techniques, our results show that structural comparability exists between rFIX and the FIX region of rFIX-Fc. In addition, changes in the structure and dynamics of both proteins, in response to calcium binding, a requirement for FIX function, are also highly comparable. In the case of Fc and Fc region of rFIX-Fc, conformational comparability is also established. These biophysical results further support the conclusion that fusing an immunoglobulin gamma 1 Fc to rFIX does not significantly alter the higher-order structure of FIX or Fc, Ca binding to FIX, or Fc functionality.
机译:正在开发用于治疗血友病B的长效重组因子IX -Fc融合蛋白(rFIX-Fc),目前正处于后期临床研究中。通过限制注射频率和维持疗效,rFIX-Fc显示出有望成为B型血友病患者的新治疗选择。但是,除获得临床试验外,在获得监管机构批准之前,rFIX-Fc还必须经过严格的分析和生物学测试。该测试包括需要了解这种蛋白质的高阶结构和动力学。在这项研究中,我们使用氢/氘交换质谱和差示扫描量热法研究并比较了rFIX-Fc,rFIX和Fc的生物物理特性。在这些技术的限制内,我们的结果表明,rFIX和rFIX-Fc的FIX区域之间存在结构可比性。另外,响应钙离子的结合,这两种蛋白质的结构和动力学变化都是FIX功能的必要条件,也是高度可比的。在rFIX-Fc的Fc和Fc区域的情况下,也建立了构象可比性。这些生物物理结果进一步支持以下结论:将免疫球蛋白伽玛1 Fc与rFIX融合不会显着改变FIX或Fc的高级结构,Ca与FIX的结合或Fc功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号